Tempus AI Raises $410M in IPO, Sees Revenue Surge

Tempus AI Raises $410M in IPO, Stock Closes Up 8.7%

Tempus AI Inc., a leading provider of medical testing services and clinical software, marked a successful debut on the Nasdaq today, with its stock price surging 8.7%. The initial public offering (IPO) generated $410 million, with Tempus AI selling 11 million shares at $37 each, the high end of its initial target range. The company now boasts a market capitalization of approximately $6.65 billion.